|
1E6F
Human MIR-receptor, repeat 11
Deposited 2000-08-15
|
Different construct
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1508–1650(143 aa)
Fragment:IGF-II-BINDING DOMAIN, REPEAT 11, RESIDUES 1508-1650
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.7;PRECIPITANT: 0.2 M AMMONIUM ACETATE, 0.1 M CACODYLATE PH 5 28% PEG 4000. PROTEIN SOLUTION: 8 MG/ML IN 10 MM TRIS-HCL PH7.5, 150 MM N VAPOUR DIFFUSION, HANGING DROPS,1:1 RATIO.
|
Resolution 1.75 Å
R-free 0.273
|
|
1E6F
Human MIR-receptor, repeat 11
Deposited 2000-08-15
|
Different construct
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
1508–1650(143 aa)
Fragment:IGF-II-BINDING DOMAIN, REPEAT 11, RESIDUES 1508-1650
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.7;PRECIPITANT: 0.2 M AMMONIUM ACETATE, 0.1 M CACODYLATE PH 5 28% PEG 4000. PROTEIN SOLUTION: 8 MG/ML IN 10 MM TRIS-HCL PH7.5, 150 MM N VAPOUR DIFFUSION, HANGING DROPS,1:1 RATIO.
|
Resolution 1.75 Å
R-free 0.273
|
|
1GP0
Human IGF2R domain 11
Deposited 2001-10-29
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1508–1650(143 aa)
Fragment:IGF-II-BINDING DOMAIN, REPEAT 11 RESIDUES 1508-1650
|
Not recorded
|
SO4 SULFATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 8.5;PROTEIN WAS CRYSTALLIZED FROM 0.2 M LITHIUM SULFATE, 0.1 M TRIS HCL PH 8.5, 30 % PEG 4000
|
Resolution 1.40 Å
R-free 0.237
|
|
1GP3
Human IGF2R domain 11
Deposited 2001-10-29
|
Different construct
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1508–1650(143 aa)
Fragment:IGF-II BINDING DOMAIN REPEAT 11 RESIDUES 1508-1650
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 8.5;PROTEIN WAS CRYSTALLIZED FROM 0.2 M SODIUM ACETATE, 0.1 M TRIS HCL PH 8.5, 30 % W/V PEG 4000
|
Resolution 1.95 Å
R-free 0.255
|
|
1GQB
HUMAN MIR-RECEPTOR, REPEAT 11
Deposited 2001-11-22
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1508–1650(143 aa)
Fragment:IGF-II-BINDING DOMAIN, REPEAT 11, RESIDUES 1508-1650
|
Not recorded
|
BR BROMIDE ION × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.6;PRECIPITANT: 0.2 M AMMONIUM ACETATE, 0.1 M CACODYLATE PH 5, 28% PEG 4000. PROTEIN SOLUTION: 8 MG/ML IN 10 MM TRIS-HCL PH7.5, 150 MM VAPOUR DIFFUSION, HANGING DROPS,1:1 RATIO.
|
Resolution 1.80 Å
R-free 0.253
|
|
1GQB
HUMAN MIR-RECEPTOR, REPEAT 11
Deposited 2001-11-22
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
1508–1650(143 aa)
Fragment:IGF-II-BINDING DOMAIN, REPEAT 11, RESIDUES 1508-1650
|
Not recorded
|
BR BROMIDE ION × 6
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.6;PRECIPITANT: 0.2 M AMMONIUM ACETATE, 0.1 M CACODYLATE PH 5, 28% PEG 4000. PROTEIN SOLUTION: 8 MG/ML IN 10 MM TRIS-HCL PH7.5, 150 MM VAPOUR DIFFUSION, HANGING DROPS,1:1 RATIO.
|
Resolution 1.80 Å
R-free 0.253
|
|
1JWG
VHS Domain of human GGA1 complexed with cation-independent M6PR C-terminal Peptide
Deposited 2001-09-04
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain C
2479–2491(13 aa)
Fragment:C-terminal fragment
|
Not recorded
|
IOD IODIDE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;293 K;PEG 3350, ammonium iodide, Tris, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 2.00 Å
R-free 0.261
|
|
1JWG
VHS Domain of human GGA1 complexed with cation-independent M6PR C-terminal Peptide
Deposited 2001-09-04
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain D
2479–2491(13 aa)
Fragment:C-terminal fragment
|
Not recorded
|
IOD IODIDE ION × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;293 K;PEG 3350, ammonium iodide, Tris, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 2.00 Å
R-free 0.261
|
|
1LF8
Complex of GGA3-VHS Domain and CI-MPR C-terminal Phosphopeptide
Deposited 2002-04-10
|
Different construct
Different mutation/modification
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain E
2480–2491(12 aa)
Fragment:C-terminus (residues 2480-2491)
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;100mM CAPS 10.2-11.0, 200 mM Lithium Sulfate, 1.3-2M Sodium/Potassium phosphate, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 2.30 Å
R-free 0.255
|
|
1LF8
Complex of GGA3-VHS Domain and CI-MPR C-terminal Phosphopeptide
Deposited 2002-04-10
|
Different construct
Different mutation/modification
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain F
2480–2491(12 aa)
Fragment:C-terminus (residues 2480-2491)
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;100mM CAPS 10.2-11.0, 200 mM Lithium Sulfate, 1.3-2M Sodium/Potassium phosphate, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 2.30 Å
R-free 0.255
|
|
1LF8
Complex of GGA3-VHS Domain and CI-MPR C-terminal Phosphopeptide
Deposited 2002-04-10
|
Different construct
Different mutation/modification
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain G
2480–2491(12 aa)
Fragment:C-terminus (residues 2480-2491)
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;100mM CAPS 10.2-11.0, 200 mM Lithium Sulfate, 1.3-2M Sodium/Potassium phosphate, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 2.30 Å
R-free 0.255
|
|
1LF8
Complex of GGA3-VHS Domain and CI-MPR C-terminal Phosphopeptide
Deposited 2002-04-10
|
Different construct
Different mutation/modification
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain H
2480–2491(12 aa)
Fragment:C-terminus (residues 2480-2491)
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;100mM CAPS 10.2-11.0, 200 mM Lithium Sulfate, 1.3-2M Sodium/Potassium phosphate, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 2.30 Å
R-free 0.255
|
|
2CNJ
NMR studies on the interaction of Insulin-Growth Factor II (IGF-II) with IGF2R domain 11
Deposited 2006-05-22
|
Different construct
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain D
1508–1650(143 aa)
Fragment:DOMAIN 11, RESIDUES 1508-1650
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 5.5;298 K;Pressure 1.0
NMR sample composition
5% D2O/ 95% H2O
|
Resolution not provided
|
|
2V5N
STRUCTURE OF HUMAN IGF2R DOMAINS 11-12
Deposited 2007-07-06
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1508–1799(292 aa)
Fragment:DOMAINS 11 AND 12, RESIDUES 1508-1799
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7.5;0.2 M POTASSIUM SODIUM TARTRATE, 20% (W/V) PEG 3350, pH 7.5
|
Resolution 3.20 Å
R-free 0.317
|
|
2V5O
STRUCTURE OF HUMAN IGF2R DOMAINS 11-14
Deposited 2007-07-06
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1508–2128(621 aa)
Fragment:DOMAINS 11-14, RESIDUES 1508-2128
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 3
CL CHLORIDE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.4;0.1 M MES PH6.4, 2.5% (W/V) PEG 3000
|
Resolution 2.91 Å
R-free 0.304
|
|
2V5P
COMPLEX STRUCTURE OF HUMAN IGF2R DOMAINS 11-13 BOUND TO IGF-II
Deposited 2007-07-06
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
1508–1992(485 aa)
Fragment:DOMAINS 11-13, RESIDUES 1508-1992
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 9;0.1 M TRIS-HCL PH 9.0, 15% (V/V) MPD
|
Resolution 4.10 Å
R-free 0.327
|
|
2V5P
COMPLEX STRUCTURE OF HUMAN IGF2R DOMAINS 11-13 BOUND TO IGF-II
Deposited 2007-07-06
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
1508–1992(485 aa)
Fragment:DOMAINS 11-13, RESIDUES 1508-1992
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 9;0.1 M TRIS-HCL PH 9.0, 15% (V/V) MPD
|
Resolution 4.10 Å
R-free 0.327
|
|
5IEI
X-ray crystallographic structure of a high affinity IGF2 antagonist (Domain11 AB5 RHH) based on human IGF2R domain 11
Deposited 2016-02-25
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1508–1649(142 aa)
Fragment:UNP residues 1508-1649
|
Mutation:Q1569R, P1597H, S1602H
|
GOL GLYCEROL × 1
EDO 1,2-ETHANEDIOL × 2
SO4 SULFATE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;291 K;2.0 M Ammonium Sulphate, 0.1M Bis-(2-hydroxyethyl)imino-tris(hydroxymethyl methane, pH 7.0.
|
Resolution 2.80 Å
R-free 0.249
|
|
6N5X
Crystal structure of the SNX5 PX domain in complex with the CI-MPR (space group P212121 - Form 1)
Deposited 2018-11-22
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
2347–2377(31 aa)
|
Not recorded
|
GOL GLYCEROL × 1
JEF O-(O-(2-AMINOPROPYL)-O'-(2-METHOXYETHYL)POLYPROPYLENE GLYCOL 500) × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 6.5;293 K;75% of 0.2 M (NH4)SO4, 0.1 M MES pH 6.5, 30% (w/v) PEG5000 MME + 15% glycerol + 40% v/v Polypropylene glycol P400
|
Resolution 2.05 Å
R-free 0.234
|
|
6N5Y
Crystal structure of the SNX5 PX domain in complex with the CI-MPR (space group P212121 - Form 1)
Deposited 2018-11-22
|
Different construct
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
2347–2377(31 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 6.5;293 K;75% of 0.2 M (NH4)SO4, 0.1 M MES pH 6.5, 30% (w/v) PEG5000 MME + 15% glycerol + 30% v/v (+/-)-2-Methyl-2,4-pentanediol
|
Resolution 2.26 Å
R-free 0.235
|
|
6P8I
N-terminal 5 domains of IGFIIR
Deposited 2019-06-07
|
Different construct
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
36–763(728 aa)
Fragment:N-terminal 5 domains
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.5;292.15 K;100mM ammonium citrate dibasic, 20% PEG 3350
|
Resolution 2.54 Å
R-free 0.282
|
|
6V02
N-terminal 5 domains of CI-MPR
Deposited 2019-11-18
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
43–763(721 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;292.15 K;100 mM HEPES pH 7.0, 30% Jeffamine ED-2003
|
Resolution 2.46 Å
R-free 0.308
|
|
6Z30
Human cation-independent mannose 6-phosphate/ IGF2 receptor domains 9-10
Deposited 2020-05-19
|
Different construct
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1222–1510(289 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 9;298 K;0.1 M SPG buffer (succinic acid, sodium dihydrogen phosphate monohydrate, glycine) pH 9, 25 % PEG 1500
|
Resolution 1.50 Å
R-free 0.228
|
|
6Z31
Human cation-independent mannose 6-phosphate/ IGF2 receptor domain 8
Deposited 2020-05-19
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1082–1220(139 aa)
|
Not recorded
|
CL CHLORIDE ION × 1
NA SODIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;298 K;1.5 M Ammonium sulphate, 0.1 M Tris pH 8.5, 12 % glycerol
|
Resolution 2.56 Å
R-free 0.251
|
|
6Z31
Human cation-independent mannose 6-phosphate/ IGF2 receptor domain 8
Deposited 2020-05-19
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
1082–1220(139 aa)
|
Not recorded
|
CL CHLORIDE ION × 1
NA SODIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;298 K;1.5 M Ammonium sulphate, 0.1 M Tris pH 8.5, 12 % glycerol
|
Resolution 2.56 Å
R-free 0.251
|
|
6Z32
Human cation-independent mannose 6-phosphate/IGF2 receptor domains 7-11
Deposited 2020-05-19
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
927–1649(723 aa)
|
Not recorded
|
SO4 SULFATE ION × 1
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;298 K;0.1 M MES pH 6.5, 1.6 M MgSO4, 10 mM mannose 6-phosphate
|
Resolution 3.47 Å
R-free 0.300
|
|
6Z32
Human cation-independent mannose 6-phosphate/IGF2 receptor domains 7-11
Deposited 2020-05-19
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Other combination
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
927–1649(723 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;298 K;0.1 M MES pH 6.5, 1.6 M MgSO4, 10 mM mannose 6-phosphate
|
Resolution 3.47 Å
R-free 0.300
|
|
8AFZ
Architecture of the ESCPE-1 membrane coat
Deposited 2022-07-18
|
Different construct
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain C
2347–2377(31 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE;Incubation time 30s
Blotting time 2s
|
Resolution 10.00 Å
|